United States
Germany
Japan
United Kingdom
China
AKT1 (NM_005163) Human Untagged Clone
CAT＃: SC116883
AKT1 (untagged)-Human v-akt murine thymoma viral oncogene homolog 1 (AKT1), transcript variant 1
CNY 3,656.00
| Cited in 7 publications. |
Product images
CNY 1,999.00
CNY 2,700.00
热销推荐Specifications
| Product Data | |
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Synonyms | AKT; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA |
| Vector | pCMV6-XL5 |
| E. coli Selection | Ampicillin (100 ug/mL) |
| Mammalian Cell Selection | None |
| Sequence Data |
>OriGene ORF sequence for NM_005163 edited
ATGAGCGACGTGGCTATTGTGAAGGAGGGTTGGCTGCACAAACGAGGGGAGTACATCAAG ACCTGGCGGCCACGCTACTTCCTCCTCAAGAATGATGGCACCTTCATTGGCTACAAGGAG CGGCCGCAGGATGTGGACCAACGTGAGGCTCCCCTCAACAACTTCTCTGTGGCGCAGTGC CAGCTGATGAAGACGGAGCGGCCCCGGCCCAACACCTTCATCATCCGCTGCCTGCAGTGG ACCACTGTCATCGAACGCACCTTCCATGTGGAGACTCCTGAGGAGCGGGAGGAGTGGACA ACCGCCATCCAGACTGTGGCTGACGGCCTCAAGAAGCAGGAGGAGGAGGAGATGGACTTC CGGTCGGGCTCACCCAGTGACAACTCAGGGGCTGAAGAGATGGAGGTGTCCCTGGCCAAG CCCAAGCACCGCGTGACCATGAACGAGTTTGAGTACCTGAAGCTGCTGGGCAAGGGCACT TTCGGCAAGGTGATCCTGGTGAAGGAGAAGGCCACAGGCCGCTACTACGCCATGAAGATC CTCAAGAAGGAAGTCATCGTGGCCAAGGACGAGGTGGCCCACACACTCACCGAGAACCGC GTCCTGCAGAACTCCAGGCACCCCTTCCTCACAGCCCTGAAGTACTCTTTCCAGACCCAC GACCGCCTCTGCTTTGTCATGGAGTACGCCAACGGGGGCGAGCTGTTCTTCCACCTGTCC CGGGAGCGTGTGTTCTCCGAGGACCGGGCCCGCTTCTATGGCGCTGAGATTGTGTCAGCC CTGGACTACCTGCACTCGGAGAAGAACGTGGTGTACCGGGACCTCAAGCTGGAGAACCTC ATGCTGGACAAGGACGGGCACATTAAGATCACAGACTTCGGGCTGTGCAAGGAGGGGATC AAGGACGGTGCCACCATGAAGACCTTTTGCGGCACACCTGAGTACCTGGCCCCCGAGGTG CTGGAGGACAATGACTACGGCCGTGCAGTGGACTGGTGGGGGCTGGGCGTGGTCATGTAC GAGATGATGTGCGGTCGCCTGCCCTTCTACAACCAGGACCATGAGAAGCTTTTTGAGCTC ATCCTCATGGAGGAGATCCGCTTCCCGCGCACGCTTGGTCCCGAGGCCAAGTCCTTGCTT TCAGGGCTGCTCAAGAAGGACCCCAAGCAGAGGCTTGGCGGGGGCTCCGAGGACGCCAAG GAGATCATGCAGCATCGCTTCTTTGCCGGTATCGTGTGGCAGCACGTGTACGAGAAGAAG CTCAGCCCACCCTTCAAGCCCCAGGTCACGTCGGAGACTGACACCAGGTATTTTGATGAG GAGTTCACGGCCCAGATGATCACCATCACACCACCTGACCAAGATGACAGCATGGAGTGT GTGGACAGCGAGCGCAGGCCCCACTTCCCCCAGTTCTCCTACTCGGCCAGCGGCACGGCC TGA >OriGene 5' read for NM_005163 unedited
GTCACCATTTGTATACGACTCATATAGGCGGCNCGCGATTCGGCACGAGGAAGTACTTGG GGCATTTCCCTCTTTGGAGGCTGTGGCCAGGCCAGCTGGGCTCGGGGAGCGCCAGCCTGA GAGGAGCGCGTGAGCGTTGCGGGAGCCTCGGGCACCATGAGCGACGTGGCTATTGTGAAG GAGGGTTGGCTGCACAAACGAGGGGAGTACATCAAGACCTGGCGGCCACGCTACTTCCTC CTCAAGAATGATGGCACCTTCATTGGCTACAAGGAGCGGCCGCAGGATGTGGACCAACGT GAGGCTCCCCTCAACAACTTCTCTGTGGCGCAGTGCCAGCTGATGAAGACGGAGCGGCCC CGGCCCAACACCTTCATCATCCGCTGCCTGCAGTGGACCACTGTCATCGAACGCACCTTC CATGTGGAGACTCCTGAGGAGCGGGAGGAGTGGACAACCGCCATCCAGACTGTGGCTGAC GGCCTCAAGAAGCAGGAGGAGGAGGAGATGGACTTCCGGTCGGGCTCACCCAGTGACAAC TCAGGGGCTGAAGAGATGGAGGTGTCCCTGGCCAAGCCCAAGCACCGCGTGACCATGAAC GANGTTGAGTACCTGAAGCTGCTGGGCAAGGGCACTNTCGGCAAGGTGATCCTGGTGAAG GAGAAGCCACAGGCCGCTACTACGCCATGAAGATCCTCAAGAANGAGTCATCGTGGCCAA GGACGANGTGGCCCACACACTCACCGAGAACCCGCGTCCTGCANAACTCCAGGCACCCCT TNCTCACAGCCCTGAAGTACTCTTTCCAGACCACGACCGCCTCTGCTTTGTCATGGAGTA CAGCCACGGGGGCGAGCTGNTCTTCCACCTGTCCCGGNAGCGTGTGTNCTCCGAGACCGG CCCGCTTCTATGCGCTGAGAT >OriGene 3' read for NM_005163 unedited
CCGCGGCACGCAATCTAGTATCGAGTTTTTTTTTTTTTTTTTTGAAAACAACTTTTATTG AAGAATTTGGAGGGAAGGTTCCATATTATATTATAATAGTAAAAATACTAAAGTTGAATG TTGTAAAAAAACGCCGTGGTGCATCGGCAGCGGCAGCGTCTGGCCAGGATGCGTGGAGGG GCCCATGGATGGCCACCCCCACAGGGAGTCAGGGAGGGCCTGGGGCGACAGCGGAAAGGT TAAGCGTCGAAAAGGTCAAGTGCTACCGTGGAGAGATCATCTGAGGGGGAGGCTCCCGGT GGGACAGTCACCAAGAACTGTGACACAGAAGGGGAAGGGGGAGGGCTTTCCTGTCACAAA GATTAAAAACCCCCAAAATGCATTTGAACAACATAATACACAATAACAAATTTAAACCTT GCTCCTCTGTCCCACTGGGTAAACCCTGGCCCATCCCCCATCCCTGGTCCCATCCCATGG GCCCAGCCTCCGATGACGTCCTCAGAGACACGGCCTTATTGCTGGGGGGCTGCTGTGTGC CTGCCACCCCCAGGAGAGGGTGCTGGCCAGCATACCATAGTGAGGTTGCATCTGGTGCCA CCAGGTTGAACTGATGCCCATGGCCCCAGAGAGATGACAGATAGCTGGTGACAGACAGCC CAGGGCGGCTGGCTGACAGAGTGAGGGGACACATGGGCAGGACCTTGCTGGCCCCCCAAT GCCACATTGCGCATAGCTGCAGAAATCCCTAACATTTCCCTACGTGAATCGGATTGTTCT GAAGGCTGAAGCCCCCCCCGGAGGACAAACTGGATGAATAAATAAAACCCGCGGATATTT TTTTTCCTCCCCGCTGCGGGGGAGTTGCTGNCCAAGCACAAAACTTTTTCTTTGGGCTCA AAGGCCCGGGGTTTTCTCATGCCCCCGGAATAAACCCTATTCCGATCTGCCCGAGGG |
| Restriction Sites | NotI-NotI |
| ACCN | NM_005163 |
| Insert Size | 2380 bp |
| OTI Disclaimer | Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP). |
| Product Components | The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water). |
| Reconstitution | 1. Centrifuge at 5,000xg for 5min. 2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA. 3. Close the tube and incubate for 10 minutes at room temperature. 4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom. 5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C. |
| Note | Plasmids are not sterile. For experiments where strict sterility is required, filtration with 0.22um filter is required. |
| Reference Data | |
| RefSeq | NM_005163.2, NP_005154.2 |
| RefSeq Size | 3008 bp |
| RefSeq ORF | 1443 bp |
| Locus ID | 207 |
| UniProt ID | P31749 |
| Domains | pkinase, S_TK_X, TyrKc, PH, S_TKc |
| Protein Families | Druggable Genome, ES Cell Differentiation/IPS, Protein Kinase |
| Protein Pathways | Acute myeloid leukemia, Adipocytokine signaling pathway, Apoptosis, B cell receptor signaling pathway, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Endometrial cancer, ErbB signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, Glioma, Insulin signaling pathway, Jak-STAT signaling pathway, MAPK signaling pathway, Melanoma, mTOR signaling pathway, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Renal cell carcinoma, Small cell lung cancer, T cell receptor signaling pathway, Tight junction, Toll-like receptor signaling pathway, VEGF signaling pathway |
| Gene Summary | This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020] Transcript Variant: This variant (1) is the longest transcript. Variants 1, 2 and 3 encode the same protein. |
Citations (7)
| The use of this cDNA Clones has been cited in the following citations: |
|---|
|
Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
,null,
Biomedicine pharmacotherapy = Biomedecine pharmacotherapie
,PubMed ID 29807229
[AKT1]
|
|
Tumors with AKT1E17K mutations are rational targets for single agent or combination therapy with AKT inhibitors
,Davies, B;Guan, N;Logie, A;Crafter, C;Hanson, L;Jacobs, V;James, N;Dudley, P;Jacques, K;Ladd, B;D'Cruz, CM;Zinda, M;Lindemann, J;Kodaira, M;Tamura, K;Jenkins, EL;,
Mol. Cancer Ther.
,PubMed ID 26351323
[AKT1]
|
|
Role of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced autophagy in HeLa cells
,Roy, B;Pattanaik, AK;Das, J;Bhutia, SK;Behera, B;Singh, P;Maiti, TK;,
Chem. Biol. Interact., Feb 2014.
,PubMed ID 24434245
[AKT1]
|
|
Cluster of Differentiation 166 (CD166) regulated by Phosphatidylinositide 3-Kinases (PI3K)/AKT signaling to exert its anti-apoptotic role via Yes associated protein (YAP) in liver cancer
,Ma, L;Wang, J;Lin, J;Pan, Q;Yu, Y;Sun, F;,
J. Biol. Chem., Jan 2014.
,PubMed ID 24482231
[AKT1]
|
|
Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy
,null,
Autophagy
,PubMed ID 23169238
[AKT1]
|
|
Visualization of phosphoinositides via the development of the transient expression system of a cyan fluorescent protein in the red alga Porphyra yezoensis.
,null,
Marine biotechnology (New York, N.Y.)
,PubMed ID 19153794
[AKT1]
|
|
Protection from angiotensin II–mediated vasculotoxic and hypertensive response in mice lacking PI3K gamma
,Carmine Vecchione, Enrico Patrucco, Gennaro Marino, Laura Barberis, Roberta Poulet, Alessandra Aretini, Angelo Maffei, Maria Teresa Gentile, Marianna Storto, Ornella Azzolino, Mara Brancaccio, Gian Luca Colussi, Umberto Bettarini, Fiorella Altruda, Lorenzo Silengo, Guido Tarone, Mathias P. Wymann, Emilio Hirsch, and Giuseppe Lembo,
J. Exp. Med. 2005 Apr 18;201(8):1217-28.
[AKT1]
|
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
Other Versions
| SKU | Description | Size | Price |
|---|---|---|---|
| RC220257 | AKT1 (Myc-DDK-tagged)-Human v-akt murine thymoma viral oncogene homolog 1 (AKT1), transcript variant 1 |
CNY 3,656.00 |
|
| RC220257L1 | Lenti ORF clone of Human v-akt murine thymoma viral oncogene homolog 1 (AKT1), transcript variant 1, Myc-DDK-tagged |
CNY 6,056.00 |
|
| RC220257L2 | Lenti ORF clone of Human v-akt murine thymoma viral oncogene homolog 1 (AKT1), transcript variant 1, mGFP tagged |
CNY 6,056.00 |
|
| RC220257L3 | Lenti ORF clone of Human v-akt murine thymoma viral oncogene homolog 1 (AKT1), transcript variant 1, Myc-DDK-tagged |
CNY 6,056.00 |
|
| RC220257L4 | Lenti ORF clone of Human v-akt murine thymoma viral oncogene homolog 1 (AKT1), transcript variant 1, mGFP tagged |
CNY 6,056.00 |
|
| RG220257 | AKT1 (tGFP-tagged) - Human v-akt murine thymoma viral oncogene homolog 1 (AKT1), transcript variant 1 |
CNY 5,256.00 |
|
| SC323430 | AKT1 (untagged)-Kinase deficient mutant (K179M) of Human v-akt murine thymoma viral oncogene homolog 1 (AKT1), transcript variant 1 |
CNY 3,656.00 |
